Antibodies against native DNA. the methods for their demonstration. their diagnostic and pathogenetic importance in systemic lupus erythematosus
Kostadinova, D.A.; Razboĭnikov, S.
Vutreshni Bolesti 15(2): 18-26
1976
ISSN/ISBN: 0506-2772 PMID: 59467 Document Number: 109737
Document emailed within 1 workday
Related Documents
Osnos, M.C.; Eyquem, A. 1979: Systemic lupus erythematosus and anti-native desoxyribonucleic acid antibodies: clinical and laboratory comparison of the results given by two methods of detection La Nouvelle Presse Medicale 8(30): 2451-2456Maradona Hidalgo, J.A.; Alvarez Alvarez, C.; Asensi Alvarez, V.; Diéguez Junquera, M.A. 1985: Systemic lupus erythematosus and anti-native-DNA antibodies measured using Crithidia luciliae Medicina Clinica 84(10): 416-417
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Sepúlveda, C.; Rivero, S.; Jacobelli, S. 1985: Anti-DNA antibodies in systemic lupus erythematosus. Study of 2 methods of detection Revista Medica de Chile 113(2): 89-93
Riazantseva, T.A.; Shakhanina, K.L.; Aroian, A.A.; Speranskiĭ, A.I. 1987: Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics) Terapevticheskii Arkhiv 59(8): 86-91
Manent-Ducreuzet, C.; Margulis, J.; Kahn, M.F. 1981: Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(11): 705-712
Mach, P.S.; Kharouby, M.; Lutcher, F.; Olivier, J.L.; Bazely, N.; Dougados, M.; Amor, B. 1984: The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus Clinical and Experimental Immunology 57(3): 535-540
Ohe, A.; Koda, S.; Negoro, N.; Okamura, M.; Amatsu, K.; Kohno, M.; Kanayama, Y.; Inoue, T.; Takeda, T. 1982: A case of hydralazine-induced lupus erythematosus with circulating antibodies to native DNA Osaka City Medical Journal 28(2): 149-151
Gutiérrez-Adrianzén, O.Augusto.; Koutouzov, S.; Mota, R.Maria.Salani.; das Chagas Medeiros, M.Maria.; Bach, J-François.; de Holanda Campos, H. 2006: Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies Journal of Rheumatology 33(8): 1538-1544
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Dixon, J.A.; Mulhern, L.M.; Whiteside, T.L.; Luksick, J. 1980: Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus Journal of Rheumatology 7(4): 544-546
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Marczak, M.; Kardaszewicz, E.; Sikora, M. 1982: Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus Polski Tygodnik Lekarski 37(12): 339-340
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
López-Longo, F.J.; Monteagudo, I.; González, C.M.; Moreno, A.C.; Rodríguez Mahou, M.; Grau, R.; Carreño, L. 1998: Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus Journal of Rheumatology 25(9): 1743-1749
Hoshino, C.; Shinomiya, N.; Yata, J. 1984: Demonstration of anti-asialo GM1 antibody and its neurocytotoxicity in the sera of systemic lupus erythematosus patients Asian Pacific Journal of Allergy and Immunology 2(2): 195-201
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Craft, J. 1992: Antibodies to sn RNPs in systemic lupus erythematosus Rheumatic Diseases Clinics of North America 18(2): 311-335
Danon, Y.L.; Garty, B.Z.; Nitzan, M. 1984: Antineuroblastoma antibodies in systemic lupus erythematosus Israel Journal of Medical Sciences 20(8): 720-721